Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?
- PMID: 26635211
- DOI: 10.1038/nrneurol.2015.224
Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?
Abstract
A randomized, double-blind, phase III trial of generic glatiramer acetate has shown equivalent efficacy and safety compared with the approved formulation, Copaxone. The impact of approval of generic glatiramer acetate, however, will mainly depend on the pricing of the drug.
Comment on
-
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.JAMA Neurol. 2015 Dec;72(12):1433-41. doi: 10.1001/jamaneurol.2015.2154. JAMA Neurol. 2015. PMID: 26458034 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
